logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2019 — Melanoma: inflammatory markers associated with lower treatment response and survival

High CRP and IL-6 expression may prognosticate poorly in stage III-IV melanoma.